Author： Fumoleau P. Seidman A.D. Trudeau M.E. Chevallier B. Huinink W.W.T.B.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.12, 1997-12, pp. : 1853-1866
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Docetaxel: a workhorse in breast cancer therapy
Inpharma, Vol. 1, Iss. 1273, 2001-01 ,pp. :
Access to resources
Recommend
Docetaxel: A Review of its Use in Metastatic Breast Cancer
By Lyseng-Williamson Katherine A. Fenton Caroline
Drugs, Vol. 65, Iss. 17, 2005-01 ,pp. :
Trastuzumab plus docetaxel in metastatic breast cancer
Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. :
MVP active in metastatic breast cancer
Inpharma, Vol. 1, Iss. 1484, 2005-01 ,pp. :